Recent work has demonstrated that hepatic ALT protein expression is increased in mice and humans with obesity and that suppressing the expression of ALT enzymes in liver has antidiabetic effects by reducing alanine-stimulated gluconeogenesis (24, 25). The gene discussed is GPT; the disease is obesity disorder.